Francesco Ancona

Dr. Francesco Ancona


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
DRDamiano Regazzoli
Damiano Regazzoli
FAFrancesco Ancona
Francesco Ancona
NTNicola Trevisi
Nicola Trevisi
FGFabrizio Guarracini
Fabrizio Guarracini
ARAndrea Radinovic
Andrea Radinovic
PMPatrizio Mazzone
Patrizio Mazzone
Atrial fibrillation (AF) is the most common clinically relevant cardiac arrhythmia. AF poses patients at increased risk of thromboembolism, in particular ischemic stroke. The CHADS2 and CHA2DS2-VASc scores are useful in the assessment of thromboembolic risk in nonvalvular AF and are utilized in decision-making about treatment with oral anticoagulation (OAC). However, OAC is underutilized due to poor patient compliance and contraindications, especially major bleedings. The Virchow triad synthesizes the pathogenesis of thrombogenesis in AF: endocardial dysfunction, abnormal blood stasis, and altered hemostasis. This is especially prominent in the left atrial appendage (LAA), where the low flow reaches its minimum. The LAA is the remnant of the embryonic left atrium, with a complex and variable morphology predisposing to stasis, especially during AF. In patients with nonvalvular AF, 90% of thrombi are located in the LAA. So, left atrial appendage occlusion could be an interesting and effective procedure in thromboembolism prevention in AF. After exclusion of LAA as an embolic source, the remaining risk of thromboembolism does not longer justify the use of oral anticoagulants. Various surgical and catheter-based methods have been developed to exclude the LAA. This paper reviews the physiological and pathophysiological role of the LAA and catheter-based methods of LAA exclusion.

24 February 2021 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
FAFrancesco Ancona
Francesco Ancona
FMFrancesco Melillo
Francesco Melillo
FCFrancesco Calvo
Francesco Calvo
NHNadia Attalla El Halabieh
Nadia Attalla El Halabieh
SSStefano Stella
Stefano Stella
EAEustachio Agricola
Eustachio Agricola
Aims : The aim of this study is to analyse the prognostic implications of right ventricular (RV) dysfunction as detected by strain analysis in patients with severe tricuspid regurgitation (TR). The evaluation of RV systolic function in presence of severe TR is of paramount importance for operative risk stratification; however, it remains challenging, as conventional echocardiographic indexes usually lead to overestimation. Methods and results: We enrolled 250 consecutive patients with severe TR referred to our centre. Baseline clinical and echocardiographic data and follow-up outcomes were collected. Patients were predominantly female, with multiple cardiovascular risk factors and comorbidities, history of heart failure, and atrial fibrillation. Most of them had presented with clinical signs of RV heart failure (RVHF) and advanced New York Heart Association class. The RV strain analysis [both RV free wall longitudinal strain (RVFWLS) and RV global longitudinal strain (RVGLS)] reclassified ∼42–56% of patients with normal RV systolic function according to conventional parameters in patients with impaired RV systolic function. RVFWLS ≤17% (absolute values, AUC: 0.66, P = 0.002) predicted the presence of RVHF [odds ratio (OR) 0.93, P = 0.01]. At follow-up, patients with RVFWLS >14% (absolute values, AUC: 0.70, P = 0.001, sensitivity 72%, specificity 54%) showed a better survival (P = 0.01). Conclusion: Different ranges of RVFWLS have different implications in patients with severe TR, allowing to identify a preclinical and a clinical window, with correlations to RVHF and survival.

27 February 2016 in European Heart Journal
Verified
Journal Article
Closed access
PDF file
FAFrancesco Ancona
Francesco Ancona
LBLetizia F. Bertoldi
Letizia F. Bertoldi
FRFrancesco Ruggieri
Francesco Ruggieri
MCMarco Cerri
Marco Cerri
MMMarco Magnoni
Marco Magnoni
PCPaolo G. Camici
Paolo G. Camici
We demonstrate that in patients with stress cardiomyopathy the type of triggering event is associated with different clinical, instrumental, and laboratory features that characterize the phenotype at presentation.

1 March 2012 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
Alessandro DuranteAlessandro Durante
Alessandro Durante
GPGiovanni Peretto
Giovanni Peretto
ALAlessandra Laricchia
Alessandra Laricchia
FAFrancesco Ancona
Francesco Ancona
MSMarco Spartera
Marco Spartera
DCDomenico Cianflone
Domenico Cianflone
Renin-Angiotensin-Aldosterone (RAAS) is a hormone system which acts on multiple physiologic pathways primarily by regulating blood pressure and fluid balance, but also by local autocrine and paracrine actions. In pathophysiologic conditions RAAS also contributes to the development of atherosclerosis and its various manifestations, both directly and indirectly through the actions on other systems. RAAS mainly acts as a promoter of atherosclerosis by its action on vessels, and by promoting the developmentt of hypertension, insulin resistance and diabetes, obesity, vascular and systemic inflammation. As RAAS plays a key role in the pathogenesis of cardiovascular diseases, RAAS genes have been extensively studied as candidate genes for atherosclerosis and coronary artery disease. Several polymorphisms of its genes have been found to be in relationship with atherosclerosis and cardiovascular diseases. In this review we will discuss these issues and present the most recent advances about this topic.

13 April 2019 in Heart Failure Reviews
Verified
Journal Article
Closed access
PDF file
GMGiulia Elena Mandoli
Giulia Elena Mandoli
Matteo CameliMatteo Cameli
Matteo Cameli
GNGiuseppina Novo
Giuseppina Novo
EAEustachio Agricola
Eustachio Agricola
FRFrancesca Maria Righini
Francesca Maria Righini
OCOn behalf of the Working Group of Echocardiography of the Italian Society of Cardiology
On behalf of the Working Group of Echocardiography of the Italian Society of Cardiology

17 April 2017 in Heart
Verified
Journal Article
Closed access
PDF file
FAFrancesco Ancona
Francesco Ancona
SSStefano Stella
Stefano Stella
MTMaurizio Taramasso
Maurizio Taramasso
CMClaudia Marini
Claudia Marini
Azeem LatibAzeem Latib
Azeem Latib
EAEustachio Agricola
Eustachio Agricola
Nowadays some percutaneous options for tricuspid valve (TV) repair are available: Tricinch (4Tech Cardio, Galway, Ireland) mimicking the Kay procedure, Trialign (Mitralign, Boston, MA, USA) aiming to bicuspidise TV, MitraClip (Abbott Vascular, Abbott Park, Illinois, USA) mimicking Alfieri’s stitch, direct transcatheter annuloplasty with Cardioband (Valtech Cardio, Or Yehuda, Israel) and transcatheter Forma Repair (Edwards Lifesciences, Irvine, California, USA) providing a surface for leaflet coaptation. A multimodality imaging approach is fundamental for defining the pathophysiology of tricuspid regurgitation (TR), preprocedural planning and intraprocedural monitoring. Both 2-dimensional and 3-dimensional (3D) transthoracic echocardiography and transoesophageal echocardiography (TOE) are essential for grading and anatomical characterisation of TR, and evaluation of dimensions and function of right ventricle (RV) and estimation of pulmonary pressure. In particular, 3D echocardiography provides a better anatomical definition of TV apparatus and tricuspid annulus (TA) and additional information about the anatomical relationships of TV and surrounding structures. CT offers complementary information during the preprocedural planning especially for procedures targeting TA such as annular structure and dimensions, quality and amount of annular tissue and its relationship with the right coronary artery, and the sizing of the inferior vena cava. Moreover, appropriate patient selection is crucial. The best candidate seems to be a patient with functional TR due to predominant annular dilatation with modest apical tethering, at least partial preservation of leaflets coaptation, not severe pulmonary hypertension and not advanced RV dilation and dysfunction. An example of intraprocedural multimodality imaging approach with TOE, fluoroscopy, angiography and intracardiac echocardiography is also reported.